Last month, the Brazilian government removed Essure from the market. On February 17, 2017, ANVISA, the Brazilian equivalent of the USA’s FDA, issued Resolution 457/17, suspending the importation, distribution, marketing or use of Essure in Brazil. The Brazilian safety agency took this action in response to the FDA’s actions in